Valeant Pharmaceuticals International, Inc.

Canada

Commandez votre montre hebdomadaire Valeant Pharmaceuticals International, Inc.
Quantité totale PI 4
Quantité totale incluant filiales 1 600 (+ 1 607 pour les filiales)
Rang # Quantité totale PI 390 211
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 707 733
Activité incl filiales 2,8/5.0    219
Classe Nice dominante Publicité; Affaires commerciales

Brevets

Marques

0 0
0 0
1 0
3
 
Dernier brevet 2016 - Formulations of calcium and phos...
Premier brevet 1995 - Transcutaneous in vivo activatio...
Dernière marque 2012 - FAST&MILD ZERO
Première marque 2005 - BIOVAIL

Filiales

58 subsidiaries with IP (810 patents, 797 trademarks)

18 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2015 Invention Formulations of calcium and phosphate for oral inflammation. The present invention generally rela...
2013 Invention Device and method for teeth brightening. A device for applying a tooth brightening composition t...
2012 P/S Teeth whitening, brightening and cleaning preparations.
Invention Vision through photodynamic therapy of the eye. Photodynamic therapy of conditions of the eye, e...
Invention Method for treating neovascularization. The present invention describes an improved photodynamic ...
2009 Invention Drug delivery system for hydrophobic drugs. Compositions comprising microaggregates containing hy...
2007 Invention Vision through photodynamic therapy of the eye. Photodynamic therapy of conditions of the eye, es...
2006 P/S Selling services in relation to pharmaceuticals; marketing services in relation to pharmaceutical...
2005 Invention Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically a...
Invention Photodynamic therapy for the treatment of acne. The present method involves the photodynamic tre...
P/S Acids, chemical additives; alkalies, alkaloids, artificial sweeteners, bacteriological preparatio...
2004 Invention Immuno-adjuvant pdt treatment of metastatic tumors. Immuno-adjuvant photodynamic therapy to treat...
Invention Ethylene glycol esters as photoactive agents. New compounds useful in photodynamic therapy are of...
2003 Invention Reduced fluence rate pdt. The invention relates to the use of reduced fluency rate PDT to treat n...
Invention Treatment of macular edema. The invention relates to the use of photodynamic therapy (PDT) to tre...
2002 Invention Peg-lipid containing formulations. The invention is generally related to the field of drug delive...
Invention Method for reducing or preventing pdt related inflammation. This invention relates generally to t...
Invention Reduced fluence rate pdt. The invention relates to the use of reduced fluence rate PDT to treat n...
2001 Invention Methods, compositions and articles for reducing or preventing the effects of inflammation. A meth...
2000 Invention Bottle
Invention Use of photodynamic therapy for prevention of secondary cataracts. Photodynamic therapy to preven...
1999 Invention Ethylene glycol esters as photoactive agents. R.sup.2 is vinyl or a derivative form thereof. New...
1998 Invention Balloon catheter for photodynamic therapy. The present invention provides improved balloon cathet...
Invention Model and method for angiogenesis inhibition. The invention provides a method to inhibit the form...
1997 Invention Methods, compositions and articles for reducing or preventing the effects of inflammation. b. an ...
1995 Invention Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer. Liposomal compos...
Invention Compounds having selective activity for retinoid x receptors, and means for modulation of process...
Invention Use of green porphyrins to treat neovasculature in the eye. Photodynamic therapy of conditions of...
Invention Transcutaneous in vivo activation of photosensitive agents in blood. A method destroys or impairs...